Holst JJ, Knop FK, Vilsboll T, Krarup T, Madsbad S
(2016) has shown that when patients receive GLP-1 therapy, there may be reduced activation in brain regions associated with reward processing and motivation when viewing high-calorie food images compared to baseline or placebo conditions
iu ny gp phn lm chm qu trnh lo ha da, gip da khe mnh v ti tr hn
Pharmacological approaches include DPP-4 inhibitors, which prevent GLP-1 degradation, and GLP-1 receptor agonists, both approved by NICE for type 2 diabetes management in appropriate patients according to treatment guidelines
Evidence of Methylphenidate Effect on Mitochondria, Redox Homeostasis, and Inflammatory Aspects: Insights from Animal Studies
The current restrictions, put in place in 2023, effectively banned compounding pharmacies from legally dispensing these substances, citing safety concerns and insufficient data